CNS Pharmaceuticals, Inc. CNSP
4.93
(0.22)
(4.27%)
as of 25 Sep
- Market cap
- $7.5M
- P/E
- 0.0×
Follow CNSP
Insider Buys
alert about insiders buying in the last 12 month
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
1.98 | 3.43 | 0.26 | 2.55 | 2.88 | 8.13 | 25.38 | 0.48 | 0.73 |
Net Debt/EBITDA |
0.45 | 0.43 | 0.03 | 0.63 | 0.32 | 1.44 | 1.90 | 0.32 | (0.05) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 3.14% | 4.43% | 2.77% | 0.00% | 41.26% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.05 | 0.06 | 0.03 | 0.00 | (0.51) | (2.08) |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.87 | 1.15 | 0.75 | 0.69 | 0.93 | 0.77 | 0.92 | 0.10 | 0.51 |
Capex/Depreciation |
(4.67) | (1.27) | (0.95) | (0.37) | (0.44) | (1.61) | (1.00) | 0.00 | — |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (296.30%) | (1,703.39%) | (1,018.76%) | (213.68%) | (144.15%) | (87.78%) | (109.96%) | 2,432.35% | 72.19% | |
| (182.99%) | (285.68%) | (255.54%) | (140.06%) | (117.80%) | (79.59%) | (90.22%) | (2,163.59%) | (51.90%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | (585.43%) | (1,699.00%) | (665.82%) | 0.00% | 0.00% |
Return on Tangible Assets |
(394.33%) | (241.98%) | 415.51% | (199.66%) | (295.86%) | (69.47%) | (51.01%) | 1,146.92% | 375.04% |
Average Days of Receivables |
— | 0.00 | — | — | — | — | — | — | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Free Cash Flow per Share |
(31.22) | (534.92) | (70,719.50) | 0.00 | 0.00 | (36,679.50) | (17,868.00) | (7,164.00) | (0.20) |
Cash per Share |
16.26 | 201.92 | 2,743.50 | 0.00 | 0.00 | 70,197.50 | 36,206.50 | 5,551.00 | 0.20 |
Shareholders Equity per Share |
10.21 | 193.02 | (22,160.50) | 0.00 | 0.00 | 69,740.00 | 38,005.50 | (5,493.00) | (0.11) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
10.21 | 193.02 | (22,160.50) | 0.00 | 0.00 | 69,740.00 | 38,005.50 | (5,493.00) | (0.11) |
Free Cash Flow |
(13.83) | (17.12) | (14.14) | (10.56) | (13.54) | (7.34) | (3.57) | (0.72) | (0.11) |
Working Capital |
4.00 | 6.13 | (4.54) | 7.64 | 4.88 | 13.59 | 7.58 | (0.64) | (0.06) |
Capital Expenditures |
(0.02) | 0.00 | 0.00 | 0.00 | (0.01) | (0.02) | (0.02) | — | — |
Net Current Asset Value |
4.00 | 6.13 | (4.54) | 7.64 | 4.88 | 13.59 | 7.58 | (0.64) | (0.06) |
| Other line items | |||||||||
Quick Ratio |
1.76 | 2.91 | 0.09 | 2.04 | 1.93 | 7.37 | 23.28 | 0.45 | 0.50 |
Depreciation/Fixed assets |
0.22 | 0.55 | 0.84 | 2.07 | 0.81 | 0.47 | 1.10 | 0.00 | — |
Cash ROIC |
(117.96%) | (135.46%) | 364.24% | (56.80%) | (117.30%) | (25.83%) | (24.06%) | (249.01%) | (64.56%) |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(31.18) | (534.79) | (70,700.00) | 0.00 | 0.00 | (36,590.00) | (17,767.50) | (7,164.00) | (0.20) |
Capex per Share |
(0.04) | (0.13) | (19.50) | 0.00 | 0.00 | (89.50) | (100.50) | 0.00 | 0.00 |
Average Payables |
2.99 | 4.02 | 5.17 | 3.25 | 1.46 | 0.62 | 0.21 | 0.09 | 0.09 |
Average Assets |
8.66 | 5.20 | 7.38 | 10.91 | 12.31 | 11.88 | 4.30 | 0.34 | 0.42 |
Average Common Equity |
5.35 | 0.87 | 1.85 | 7.15 | 10.06 | 10.77 | 3.53 | (0.30) | (0.30) |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates